Regulatory press release16.12.2025 klo 09.57Chordate Medical terminates the liquidity guarantee for the common share
Regulatory press release08.12.2025 klo 17.30Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release18.11.2025 klo 20.40Notice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)
Regulatory press release18.11.2025 klo 20.30The board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting
Regulatory press release21.08.2025 klo 09.30Chordate Announces Cost Reduction and Focus on Company Sale
Press release19.08.2025 klo 09.30Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010
Regulatory press release17.07.2025 klo 16.45Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release30.06.2025 klo 19.45Notice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Regulatory press release30.06.2025 klo 19.30Chordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million
Press release27.06.2025 klo 09.30Chordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010
Regulatory press release23.05.2025 klo 09.30Chordate Medical Holding AB (publ) Interim Report January-March 2025
Regulatory press release21.05.2025 klo 17.15Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)
Press release20.05.2025 klo 12.00BioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia
Press release13.05.2025 klo 11.45Chordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor
Regulatory press release07.05.2025 klo 11.55Chordate Medical terminates the liquidity provider agreement for the preference share